Martire, Serena http://orcid.org/0000-0001-6889-888X
Valentino, Paola
Marnetto, Fabiana
Mirabile, Luca
Capobianco, Marco
Bertolotto, Antonio
Funding for this research was provided by:
Fondazione Italiana Sclerosi Multipla (2020/S/5)
Article History
Received: 25 October 2021
Accepted: 2 March 2022
First Online: 12 March 2022
Change Date: 11 August 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: MS has nothing to disclose. VP received speaker honoraria from Biogen and Novartis, research support from Merck and grant support from Quanterix. MF received speaker honoraria from Biogen and research support from Sanofi Genzyme. ML has nothing to disclose. CM served on the scientific advisory board of Biogen, Sanofi Genzyme, Novartis, and Bayer Schering and received speaker honoraria from Almirall, Biogen, Novartis, Sanofi Genzyme, and Teva. BA served on the scientific advisory board of Almirall, Bayer, Biogen, and Genzyme; received speaker honoraria from Biogen, Novartis and Sanofi and grant support from Almiral, Biogen, Associazione San Luigi Gonzaga ONLUS, Fondazione per la Ricerca Biomedica ONLUS, Mylan, Novartis and the Italian Multiple sclerosis Society.
: The study was approved by the Ethical committee of San Luigi Gonzaga University Hospital (approvals number 18390/2019). Written informed consent was obtained from each participant.